Natixis’s Biomea Fusion BMEA Stock Holding History

Natixis’s Portfolio BMEA Stock Details BMEA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-19,500	Closed	-$297K	–	1009
2024 Q1	$297K	Buy	19,500 +7,700	+65%	+$127K	﹤0.01%	678
2023 Q4	$171K	Buy	+11,800	New	+$143K	﹤0.01%	728

Other funds holding BMEA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

ACM

Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Natixis's BMEA Position: Q2 2024 in Review

Natixis sold out of Biomea Fusion (BMEA) in Q2 2024, closing a stake of 19,500 shares — an estimated $297K sold.

Natixis first reported a position in BMEA in Q4 2023 and held it in 2 quarters. The position peaked at $297K in Q1 2024. 107 funds tracked by Wall St. Rank hold BMEA as of Q2 2024.

Natixis reported no remaining Biomea Fusion position as of Q2 2024 after selling out during the quarter.
Natixis sold 19,500 Biomea Fusion shares in Q2 2024, an estimated $297K.
Natixis first reported a position in Biomea Fusion in Q4 2023 and held it in 2 quarters.
Natixis's Biomea Fusion position peaked at $297K in Q1 2024.
107 funds tracked by Wall St. Rank held Biomea Fusion as of Q2 2024.

Based on Natixis's 13F filing for Q2 2024, filed 13 Aug 2024.